Maria Rubio Valera
Jefe de Grupo
María Rubio-Valera, Head of Quality and Patient Safety at the Parc Sanitari Sant Joan de Déu, is a graduate (2008) and a PhD (2012) in Pharmacy from the University of Barcelona. Since 2017, she jointly leads Evaluation of Health Technologies in Primary Care and Mental Health (PRISMA) group.
Between 2013 and 2019, she was an associate professor at the University of Barcelona and has given master classes at the University of Barcelona, the Pompeu Fabra University and the Autonomous University of Barcelona.
Her research focuses on the design and evaluation of health interventions using mixed methods. Specifically, it studies the magnitude and impact of health-related behaviors, such as adherence and health promotion activities, designing targeted interventions adapted to the patient's context to improve these behaviors and evaluating their effectiveness and cost-effectiveness.
In this line of work, in September 2020, she received a Starting Grant from the European Research Council (ERC), an entity that promotes the careers of young European researchers. This is the work "IMA-cRCT - Effectiveness and cost-effectiveness of the Initial Medication Adherence intervention: a randomised controlled trial and economic model".
Professional network profiles
Last Publications
- Chavarría V, Rubio-Valera M, Domènech J, Baladon L, Mateu I, Arias de la Torre J, Alvarós J, Peña C, Dima AL and Serrano-Blanco A Patient Satisfaction and Willingness to Continue with Telemental Health Care During and After the Early Period of SARS-CoV-2 Pandemic: A User Survey TELEMEDICINE AND E-HEALTH . 30(7): .
- Sebastián D, Beltrà M, Irazoki A, Sala D, Aparicio-García P, Aris C, Alibakhshi E, Rubio-Valera M, Palacín M, Castellanos J, Lores L and Zorzano A TP53INP2-dependent activation of muscle autophagy ameliorates sarcopenia and promotes healthy aging Autophagy . 20(8): 1-10.
- Fuente M, Dima AL, Rubio-Valera M, Baladon L, Chavarría V, Fabrizio S, Peña C, Serra-Sutton V, Hermida-González P, de Loño JP, Rey-Abella ME, Aznar I and Serrano-Blanco A Evaluation of adherence to antipsychotics: A real-world data study using four different dosing assumptions. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY . 90(6): 1480-1492.
Projects
- Project name:
- SALVOVAR : A EUROPEAN MULTI-DISCIPLINARY CLINICAL PROJECT MEANT TO IMPROVE THE MANAGEMENT OF PATIENTS WITH POOR PROGNOSTIC OVARIAN CANCER AFTER NEOADJUVANT CHEMOTHERAPY: RESTORING HOPE, SALVAGING LIVES
- Leader
- Alexandra Lelia Dima
- Funding entities:
- European Commission
- Code
- 101104469
- Starting - finishing date:
- 2023 - 2028
- Project name:
- Anàlisi de les pràctiques sobre la promoció del Benestar Emocional en l’adolescència a la província de Barcelona
- Leader
- Antoni Serrano Blanco
- Funding entities:
- Diputació de Barcelona
- Code
- 2023/0025650
- Starting - finishing date:
- 2023 - 2023
- Project name:
- SGR 2022-2024_Grup de Recerca en Serveis Sanitaris i Resultats en Salut Mental (PRISMA)
- Leader
- Antoni Serrano Blanco
- Funding entities:
- Agaur - Agència de Gestió d'Ajuts Universitaris i de Recerca
- Code
- 2021 SGR 01503
- Starting - finishing date:
- 2022 - 2025
News
-
Dr Maria Rubio awarded a scientific excellence grant from the European Research Council (ERC)
This financial award will fund an intervention in several primary care centres in Catalonia and is designed to encourage people with diabetes and cardiovascular disease to begin and comply with the pharmacological treatments as prescribed by their physician.
More activities
-
XIII CIBERSAM Instrument Bank Workshop
Àgora 3 i 4. SJD Hospital de Sant Boi